drugset / Trial / NCT03199989
Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1)
Phase 3
Unknown
1254 enrolled
Peking University Cancer Hospital & Institute
Peking Union Medical College Hospital · collabPeking University People's Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to design a prospective randomized clinical trial to explore whether postoperative adjuvant chemotherapy may provide survival benefit for stage II colon cancer patients with high risk factors.Therefore the investigators can provide high level clinical evidence of indications for patients with colon cancer with stage II colon cancer.
Timeline
- Start
- 2017-06-01
- Primary completion
- 2021-07-31
- Completion
- 2024-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Capecitabine | Small molecule | — | — |
| Comparator | Oxaliplatin | Small molecule | — | — |
Indications
No indication recorded.